$79.97
0.00%
Nasdaq, Thu, Feb 27 2025
ISIN
US45332Y1091
Symbol
NARI

Inari Medical Inc Target price 2025 - Analyst rating & recommendation

Inari Medical Inc Classifications & Recommendation:

Buy
25%
Hold
75%

Inari Medical Inc Price Target

Target Price $80.00
Price $79.97
Potential
Number of Estimates 2
2 Analysts have issued a price target Inari Medical Inc 2026 . The average Inari Medical Inc target price is $80.00. This is higher than the current stock price. The highest price target is , the lowest is .
A rating was issued by 4 analysts: 1 Analysts recommend Inari Medical Inc to buy, 3 to hold and 0 to sell.
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis.
Analyst Estimates: Analysts believe that the Inari Medical Inc stock has an average upside potential 2026 of . Most analysts recommend the Inari Medical Inc stock at Hold.

Sales and Margin forecast 2024, 2025 to 2028

Create a premium account to unlock analyst estimates. Learn more

Quarter Annually
Dec '23 2024
Estimates
Revenue Million $ 493.63 603.63
28.73% 22.28%
EBITDA Margin 1.44% -4.12%
127.00% 386.04%
Net Margin -0.36% -13.65%
95.76% 3,743.29%

3 Analysts have issued a sales forecast Inari Medical Inc 2024 . The average Inari Medical Inc sales estimate is

$604m
Unlock
. This is
5.07% higher
Unlock
than the revenue of the last 12 months(TTM). The highest sales forecast is
$604m 5.12%
Unlock
, the lowest is
$603m 4.98%
Unlock
.

This results in the following potential growth metrics:

Revenue Estimates

2023 $494m 28.73%
2024
$604m 22.28%
Unlock
2025
$713m 18.04%
Unlock
2026
$833m 16.85%
Unlock
2027
$952m 14.35%
Unlock
2028
$1.1b 12.92%
Unlock

2 Analysts have issued an Inari Medical Inc EBITDA forecast 2024. The average Inari Medical Inc EBITDA estimate is

$-24.9m
Unlock
. This is
64.13% lower
Unlock
than the EBITDA of the last 12 months(TTM). The highest EBITDA forecast is
$0.0 100.00%
Unlock
, the lowest is
$-49.7m 228.27%
Unlock
.

This results in the following potential growth metrics and future EBITDA Margins:

EBITDA Estimates

2023 $7.1m 134.75%
2024
$-24.9m 449.51%
Unlock
2025
$21.4m 185.92%
Unlock
2026
$41.6m 94.85%
Unlock

EBITDA Margin

2023 1.44% 127.00%
2024
-4.12% 386.04%
Unlock
2025
3.00% 172.82%
Unlock
2026
5.00% 66.67%
Unlock

2 Inari Medical Inc Analysts have issued a net profit forecast 2024. The average Inari Medical Inc net profit estimate is

$-82.4m
Unlock
. This is
4.44% lower
Unlock
than the net profit for the last 12 months(TTM). The highest net profit forecast is
$-76.6m 2.96%
Unlock
, the lowest is
$-88.2m 11.85%
Unlock
.

This results in the following potential growth metrics and future Net Margins:

Net Profit Estimates

2023 $-1.8m 94.55%
2024
$-82.4m 4,599.98%
Unlock
2025
$880k 101.07%
Unlock
2026
$25.7m 2,821.59%
Unlock
2027
$65.5m 154.57%
Unlock
2028
$110m 68.75%
Unlock

Net Margin

2023 -0.36% 95.76%
2024
-13.65% 3,743.29%
Unlock
2025
0.12% 100.88%
Unlock
2026
3.09% 2,475.00%
Unlock
2027
6.87% 122.33%
Unlock
2028
10.27% 49.49%
Unlock

Earnings per share, P/E ratio and EV/sales Estimates 2024, 2025 to 2028

Create a premium account to unlock analyst estimates. Learn more

Quarter Annually
Dec '23 2024
Estimates
Earnings Per Share $ -0.03 -1.41
94.55% 4,600.00%
P/E negative
EV/Sales 7.63

2 Analysts have issued a Inari Medical Inc forecast for earnings per share. The average Inari Medical Inc <a href=https://blog.stocksguide.com/knowledge/eps-simply-explained>EPS is

$-1.41
Unlock
. This is
4.44% lower
Unlock
than earnings per share in the financial year 2023. The highest <a href=https://blog.stocksguide.com/knowledge/eps-simply-explained>EPS forecast is
$-1.31 2.96%
Unlock
, the lowest is
$-1.51 11.85%
Unlock
.

This results in the following potential growth metrics and future valuations:

Earnings Per Share

2023 $-0.03 94.55%
2024
$-1.41 4,600.00%
Unlock
2025
$0.02 101.42%
Unlock
2026
$0.44 2,100.00%
Unlock
2027
$1.12 154.55%
Unlock
2028
$1.89 68.75%
Unlock

P/E ratio

Current -59.13 93.89%
2024
-56.72 4.08%
Unlock
2025
5,331.33 9,499.38%
Unlock
2026
181.75 96.59%
Unlock
2027
71.40 60.72%
Unlock
2028
42.31 40.74%
Unlock

Based on analysts' sales estimates for 2024, the Inari Medical Inc stock is valued at an <a href=https://blog.stocksguide.com/knowledge/enterprise-value-sales-simply-explained>EV/Sales of

and an <a href=https://blog.stocksguide.com/knowledge/price-sales-ratio-simply-explained>P/S ratio of .

This results in the following potential growth metrics and future valuations:

EV/Sales

Current 8.01 26.54%
2024
7.63 4.77%
Unlock
2025
6.46 15.28%
Unlock
2026
5.53 14.42%
Unlock
2027
4.84 12.55%
Unlock
2028
4.28 11.44%
Unlock

P/S ratio

Current 8.15 16.36%
2024
7.76 4.83%
Unlock
2025
6.57 15.28%
Unlock
2026
5.63 14.42%
Unlock
2027
4.92 12.55%
Unlock
2028
4.36 11.44%
Unlock

Current Inari Medical Inc Upgrades & Downgrades Beta

Create a Premium account to unlock Upgrades/Downgrades. Learn more
Analyst Rating Action Date
BTIG Locked ➜ Locked Locked Jan 08 2025
Baird Locked ➜ Locked Locked Jan 07 2025
Wells Fargo Locked ➜ Locked Locked Jan 07 2025
Canaccord Genuity Locked ➜ Locked Locked Jan 07 2025
William Blair Locked ➜ Locked Locked Jan 07 2025
Piper Sandler Locked ➜ Locked Locked Jan 07 2025
Truist Securities Locked ➜ Locked Locked Dec 18 2024
Analyst Rating Date
Locked
BTIG: Locked ➜ Locked
Jan 08 2025
Locked
Baird: Locked ➜ Locked
Jan 07 2025
Locked
Wells Fargo: Locked ➜ Locked
Jan 07 2025
Locked
Canaccord Genuity: Locked ➜ Locked
Jan 07 2025
Locked
William Blair: Locked ➜ Locked
Jan 07 2025
Locked
Piper Sandler: Locked ➜ Locked
Jan 07 2025
Locked
Truist Securities: Locked ➜ Locked
Dec 18 2024

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today